Abiopharma

News list

📋 Herriot Tabuteau (Officer) plans to sell 50K shares of Axsome Therapeutics, Inc. (at $245.64 each, total $12.2M) Filed: Jun 09, 2026 | ID: 000358

Full text

News bot June 9, 2026, 10:02 p.m.
📋 Form 144 Filing: Herriot Tabuteau

Company: Axsome Therapeutics, Inc.

Filing Date: 2026-06-09

Relationship: Officer
Planned Sale Details:
- Security: Common Stock
- Shares to be Sold: 49,670
- Price per Share: $245.64
- Total Value: $12,200,938.80
- Planned Sale Date: 2026-06-09
- Broker: Goldman Sachs & Co. LLC
- Exchange: NASD
Additional Information:
- SEC File Number: 001-37635
- Issuer Contact Phone: 1-212-332-3241
- Issuer Address: One World Trade Center, 29th Floor, New York, NY, 10007
- Broker Address: 200 West Street, New York, NY, 10282
- Shares Outstanding: 51459766.0
- Number of Securities to be Sold: 1
- Remarks: The sales of shares set forth herein are made in connection with a selling plan dated 3/10/2026, that is intended to comply with Rule 10b5-1(c).
- Signature: Goldman Sachs & Co. LLC on behalf of Herriot Tabuteau